Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells

Immunity

Volumn 41, Issue 2, 2014, Pages 270-282

  Wu, Chuan ^a   Thalhamer, Theresa ^a   Franca, Rafael F ^a,c   Xiao, Sheng ^a,d   Wang, Chao ^a   Hotta, Chie ^a,e   Zhu, Chen ^a   Hirashima, Mitsuomi ^b   Anderson, Ana C ^a   Kuchroo, Vijay K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b KAGAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF SALZBURG   (Austria)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECALECTIN; HERMES ANTIGEN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; GENE EXPRESSION; GENE LOCUS; GENOMICS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; UPREGULATION;

ANIMALS; ANTIGENS, CD44; CELL DIFFERENTIATION; COLITIS; FORKHEAD TRANSCRIPTION FACTORS; GALECTINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECEPTORS, VIRUS; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84907311696     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.06.011     Document Type: Article

References (69)

1. Alam S., Li H., Margariti A., Martin D., Zampetaki A., Habi O., Cockerill G., Hu Y., Xu Q., Zeng L. Galectin-9 protein expression in endothelial cells is positively regulated by histone deacetylase 3. J.Biol. Chem. 2011, 286:44211-44217.
2. Anderson A.C., Anderson D.E., Bregoli L., Hastings W.D., Kassam N., Lei C., Chandwaskar R., Karman J., Su E.W., Hirashima M., et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 2007, 318:1141-1143.
3. Arikawa T., Watanabe K., Seki M., Matsukawa A., Oomizu S., Sakata K.M., Sakata A., Ueno M., Saita N., Niki T., et al. Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages. Clin. Immunol. 2009, 133:382-392.
4. Arikawa T., Saita N., Oomizu S., Ueno M., Matsukawa A., Katoh S., Kojima K., Nagahara K., Miyake M., Yamauchi A., et al. Galectin-9 expands immunosuppressive macrophages to ameliorate T-cell-mediated lung inflammation. Eur. J. Immunol. 2010, 40:548-558.
5. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory Tcells. Nature 2006, 441:235-238.
6. Bi S., Earl L.A., Jacobs L., Baum L.G. Structural features of galectin-9 and galectin-1 that determine distinct Tcell death pathways. J.Biol. Chem. 2008, 283:12248-12258.
7. Bluestone J.A., Abbas A.K. Natural versus adaptive regulatory Tcells. Nat. Rev. Immunol. 2003, 3:253-257.
8. Bollyky P.L., Falk B.A., Long S.A., Preisinger A., Braun K.R., Wu R.P., Evanko S.P., Buckner J.H., Wight T.N., Nepom G.T. CD44 costimulation promotes FoxP3+ regulatory Tcell persistence and function via production of IL-2, IL-10, and TGF-beta. J.Immunol. 2009, 183:2232-2241.
9. Bourguignon L.Y., Singleton P.A., Zhu H., Zhou B. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. J.Biol. Chem. 2002, 277:39703-39712.
10. Chaudhry A., Samstein R.M., Treuting P., Liang Y., Pils M.C., Heinrich J.M., Jack R.S., Wunderlich F.T., Brüning J.C., Müller W., Rudensky A.Y. Interleukin-10 signaling in regulatory Tcells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011, 34:566-578.
11. Chou F.C., Shieh S.J., Sytwu H.K. Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur. J. Immunol. 2009, 39:2403-2411.
12. Coombes J.L., Siddiqui K.R., Arancibia-Cárcamo C.V., Hall J., Sun C.M., Belkaid Y., Powrie F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory Tcells via a TGF-beta and retinoic acid-dependent mechanism. J.Exp. Med. 2007, 204:1757-1764.
13. Datto M.B., Frederick J.P., Pan L., Borton A.J., Zhuang Y., Wang X.F. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol. Cell. Biol. 1999, 19:2495-2504.
14. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425:577-584.
15. Ferber I.A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., Fathman C.G. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J.Immunol. 1996, 156:5-7.
16. Floess S., Freyer J., Siewert C., Baron U., Olek S., Polansky J., Schlawe K., Chang H.D., Bopp T., Schmitt E., et al. Epigenetic control of the foxp3 locus in regulatory Tcells. PLoS Biol. 2007, 5:e38.
17. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory Tcells. Nat. Immunol. 2003, 4:330-336.
18. Fontenot J.D., Rasmussen J.P., Gavin M.A., Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory Tcells. Nat. Immunol. 2005, 6:1142-1151.
19. Hirashima M., Kashio Y., Nishi N., Yamauchi A., Imaizumi T.A., Kageshita T., Saita N., Nakamura T. Galectin-9 in physiological and pathological conditions. Glycoconj. J. 2004, 19:593-600.
20. Jayaraman P., Sada-Ovalle I., Beladi S., Anderson A.C., Dardalhon V., Hotta C., Kuchroo V.K., Behar S.M. Tim3 binding to galectin-9 stimulates antimicrobial immunity. J.Exp. Med. 2010, 207:2343-2354.
21. Josefowicz S.Z., Lu L.F., Rudensky A.Y. Regulatory Tcells: mechanisms of differentiation and function. Annu. Rev. Immunol. 2012, 30:531-564.
22. Josefowicz S.Z., Niec R.E., Kim H.Y., Treuting P., Chinen T., Zheng Y., Umetsu D.T., Rudensky A.Y. Extrathymically generated regulatory Tcells control mucosal TH2 inflammation. Nature 2012, 482:395-399.
23. Kared H., Fabre T., Bédard N., Bruneau J., Shoukry N.H. Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C. PLoS Pathog. 2013, 9:e1003422.
24. Katoh S., Ishii N., Nobumoto A., Takeshita K., Dai S.Y., Shinonaga R., Niki T., Nishi N., Tominaga A., Yamauchi A., Hirashima M. Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am. J. Respir. Crit. Care Med. 2007, 176:27-35.
25. Kim H.P., Kim B.G., Letterio J., Leonard W.J. Smad-dependent cooperative regulation of interleukin 2 receptor alpha chain gene expression by Tcell receptor and transforming growth factor-beta. J.Biol. Chem. 2005, 280:34042-34047.
26. Lagna G., Hata A., Hemmati-Brivanlou A., Massagué J. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature 1996, 383:832-836.
27. Li X.C., Turka L.A. An update on regulatory Tcells in transplant tolerance and rejection. Nat. Rev. Nephrol. 2010, 6:577-583.
28. Liu F.T., Rabinovich G.A. Galectins: regulators of acute and chronic inflammation. Ann. N Y Acad. Sci. 2010, 1183:158-182.
29. Liu F., Pouponnot C., Massagué J. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes. Genes Dev. 1997, 11:3157-3167.
30. Liu T., Soong L., Liu G., König R., Chopra A.K. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells. Biol. Direct 2009, 4:40.
31. Lu L.H., Nakagawa R., Kashio Y., Ito A., Shoji H., Nishi N., Hirashima M., Yamauchi A., Nakamura T. Characterization of galectin-9-induced death of Jurkat Tcells. J.Biochem. 2007, 141:157-172.
32. Macías-Silva M., Abdollah S., Hoodless P.A., Pirone R., Attisano L., Wrana J.L. MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 1996, 87:1215-1224.
33. Massagué J. TGF-beta signal transduction. Annu. Rev. Biochem. 1998, 67:753-791.
34. Nagahara K., Arikawa T., Oomizu S., Kontani K., Nobumoto A., Tateno H., Watanabe K., Niki T., Katoh S., Miyake M., et al. Galectin-9 increases Tim-3+ dendritic cells and CD8+ Tcells and enhances antitumor immunity via galectin-9-Tim-3 interactions. J.Immunol. 2008, 181:7660-7669.
35. Ohkura N., Hamaguchi M., Morikawa H., Sugimura K., Tanaka A., Ito Y., Osaki M., Tanaka Y., Yamashita R., Nakano N., et al. T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 2012, 37:785-799.
36. Oomizu S., Arikawa T., Niki T., Kadowaki T., Ueno M., Nishi N., Yamauchi A., Hattori T., Masaki T., Hirashima M. Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion. PLoS ONE 2012, 7:e48574.
37. Ouyang W., Beckett O., Ma Q., Li M.O. Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory Tcell development. Immunity 2010, 32:642-653.
38. Pender M.P., McCombe P.A., Yoong G., Nguyen K.B. Apoptosis of alpha beta T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired tolerance. J.Autoimmun. 1992, 5:401-410.
39. Rabinovich G.A., Toscano M.A. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 2009, 9:338-352.
40. Reddy P.B., Sehrawat S., Suryawanshi A., Rajasagi N.K., Mulik S., Hirashima M., Rouse B.T. Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. J.Immunol. 2011, 187:5745-5755.
41. Ruan Q., Kameswaran V., Tone Y., Li L., Liou H.C., Greene M.I., Tone M., Chen Y.H. Development of Foxp3(+) regulatory tcells is driven by the c-Rel enhanceosome. Immunity 2009, 31:932-940.
42. Rubtsov Y.P., Rasmussen J.P., Chi E.Y., Fontenot J., Castelli L., Ye X., Treuting P., Siewe L., Roers A., Henderson W.R., et al. Regulatory Tcell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008, 28:546-558.
43. Rubtsov Y.P., Niec R.E., Josefowicz S., Li L., Darce J., Mathis D., Benoist C., Rudensky A.Y. Stability of the regulatory Tcell lineage invivo. Science 2010, 329:1667-1671.
44. Sakaguchi S., Miyara M., Costantino C.M., Hafler D.A. FOXP3+ regulatory Tcells in the human immune system. Nat. Rev. Immunol. 2010, 10:490-500.
45. Schlenner S.M., Weigmann B., Ruan Q., Chen Y., von Boehmer H. Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory Tcells with the exception of the gut. J.Exp. Med. 2012, 209:1529-1535.
46. Sehrawat S., Reddy P.B., Rajasagi N., Suryawanshi A., Hirashima M., Rouse B.T. Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 Tcell response. PLoS Pathog. 2010, 6:e1000882.
47. Seki M., Sakata K.M., Oomizu S., Arikawa T., Sakata A., Ueno M., Nobumoto A., Niki T., Saita N., Ito K., et al. Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum. 2007, 56:3968-3976.
48. Seki M., Oomizu S., Sakata K.M., Sakata A., Arikawa T., Watanabe K., Ito K., Takeshita K., Niki T., Saita N., et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory Tcells, and regulates experimental autoimmune arthritis. Clin. Immunol. 2008, 127:78-88.
49. Siddiqui K.R., Powrie F. CD103+ GALT DCs promote Foxp3+ regulatory Tcells. Mucosal Immunol. 2008, 1(Suppl 1):S34-S38.
50. Su E.W., Bi S., Kane L.P. Galectin-9 regulates T helper cell function independently of Tim-3. Glycobiology 2011, 21:1258-1265.
51. Sun C.M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., Belkaid Y. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3T reg cells via retinoic acid. J.Exp. Med. 2007, 204:1775-1785.
52. Takimoto T., Wakabayashi Y., Sekiya T., Inoue N., Morita R., Ichiyama K., Takahashi R., Asakawa M., Muto G., Mori T., et al. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development. J.Immunol. 2010, 185:842-855.
53. Tanikawa R., Tanikawa T., Hirashima M., Yamauchi A., Tanaka Y. Galectin-9 induces osteoblast differentiation through the CD44/Smad signaling pathway. Biochem. Biophys. Res. Commun. 2010, 394:317-322.
54. Toker A., Huehn J. To be or not to be a Treg cell: lineage decisions controlled by epigenetic mechanisms. Sci. Signal. 2011, 4:pe4.
55. Toms C., Jessup H., Thompson C., Baban D., Davies K., Powrie F. Gpr83 expression is not required for the maintenance of intestinal immune homeostasis and regulation of T-cell-dependent colitis. Immunology 2008, 125:302-312.
56. Tone Y., Furuuchi K., Kojima Y., Tykocinski M.L., Greene M.I., Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 2008, 9:194-202.
57. Tsuboi Y., Abe H., Nakagawa R., Oomizu S., Watanabe K., Nishi N., Nakamura T., Yamauchi A., Hirashima M. Galectin-9 protects mice from the Shwartzman reaction by attracting prostaglandin E2-producing polymorphonuclear leukocytes. Clin. Immunol. 2007, 124:221-233.
58. Vasta G.R. Roles of galectins in infection. Nat. Rev. Microbiol. 2009, 7:424-438.
59. Wang Z., Hong J., Sun W., Xu G., Li N., Chen X., Liu A., Xu L., Sun B., Zhang J.Z. Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- Tcells to CD4+ Tregs. J.Clin. Invest. 2006, 116:2434-2441.
60. Wang F., Wan L., Zhang C., Zheng X., Li J., Chen Z.K. Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory Tcells. Immunobiology 2009, 214:342-349.
61. Weiss J.M., Bilate A.M., Gobert M., Ding Y., Curotto de Lafaille M.A., Parkhurst C.N., Xiong H., Dolpady J., Frey A.B., Ruocco M.G., et al. Neuropilin 1 is expressed on thymus-derived natural regulatory Tcells, but not mucosa-generated induced Foxp3+ T reg cells. The Journal of experimental medicine 2012, 209:1723-1742. S1721.
62. Williams L.M., Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory Tcells requires continued expression of Foxp3. Nat. Immunol. 2007, 8:277-284.
63. Xu L., Kitani A., Stuelten C., McGrady G., Fuss I., Strober W. Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I. Immunity 2010, 33:313-325.
64. Yadav M., Louvet C., Davini D., Gardner J.M., Martinez-Llordella M., Bailey-Bucktrout S., Anthony B.A., Sverdrup F.M., Head R., Kuster D.J., et al. Neuropilin-1 distinguishes natural and inducible regulatory Tcells among regulatory Tcell subsets invivo. The Journal of experimental medicine 2012, 209:1713-1722. S1711-1719.
65. Zheng Y., Rudensky A.Y. Foxp3 in control of the regulatory Tcell lineage. Nat. Immunol. 2007, 8:457-462.
66. Zheng Y., Chaudhry A., Kas A., deRoos P., Kim J.M., Chu T.T., Corcoran L., Treuting P., Klein U., Rudensky A.Y. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009, 458:351-356.
67. Zheng Y., Josefowicz S., Chaudhry A., Peng X.P., Forbush K., Rudensky A.Y. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010, 463:808-812.
68. Zhou X., Bailey-Bucktrout S.L., Jeker L.T., Penaranda C., Martínez-Llordella M., Ashby M., Nakayama M., Rosenthal W., Bluestone J.A. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory Tcells invivo. Nat. Immunol. 2009, 10:1000-1007.
69. Zhu C., Anderson A.C., Schubart A., Xiong H., Imitola J., Khoury S.J., Zheng X.X., Strom T.B., Kuchroo V.K. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 2005, 6:1245-1252.